Type Public Website www.telik.com Founded 1988 | Traded as NASDAQ:TELK Number of employees 17 (Dec 31, 2012) | |
Industry Drug Manufacturers - Other Key people Michael M. Wick M.D.( Chairman, Chief Executive Officer, and President)Wendy K. Wee( Principal Financial & Accounting Officer )Gail L. Brown M.D.( Chief Medical Officer )(Dec 31, 2012) Headquarters | ||
Artur harutyunyan telik melik
Telik, Inc. (NASDAQ:TELK), was set up in 1988 and was reverse merged into privately held MabVax in May 2014. The major drug of the company was TELINTRA, an investigational agent that was in development for the treatment of myelodysplastic syndrome (MDS) and idiopathic chronic neutropenia.
Contents
- Artur harutyunyan telik melik
- Telik inc cffo up 31 global financial news minute with donald baillargeon
- Controversies
- References
Telik inc cffo up 31 global financial news minute with donald baillargeon
Controversies
In 2007, a class action was filed against Telik, Inc., alleging that they made false and misleading statements about the Company’s business and prospects during the Class Period.
References
Telik Wikipedia(Text) CC BY-SA